Integrum AB
6Y1
Company Profile
Business description
Integrum AB is a Sweden-based medical technology company specializing in osseointegrated, bone-anchored prosthetic systems for amputees. Its flagship product OPRA Implant System enables direct skeletal attachment of prosthetic limbs and is the only FDA-approved bone-anchored prosthetic implant system available in the U.S. The company operates as a single segment and generates it's key revenue from the U.S. market.
Contact
Gemenskapens gata 9
MolndalSE-431 53
SWET: +46 317601060
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
30 April 2027
Employees
33
Stocks News & Analysis
stocks
Apple earnings: A smooth transition despite continued memory and supply headwinds
Shares fell as investors digested the latest earnings.
stocks
Two new ASX names added to our Global Best Stock Ideas
Our full global list includes 78 companies from around the world.
stocks
Big four bank holds up in weakening economic conditions
Major bank earnings hold up in challenging conditions.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,954.90 | 54.00 | -0.60% |
| CAC 40 | 8,020.31 | 27.38 | -0.34% |
| DAX 40 | 25,864.62 | 116.47 | -0.45% |
| Dow JONES (US) | 51,786.72 | 197.26 | -0.38% |
| FTSE 100 | 10,638.43 | 122.90 | -1.14% |
| HKSE | 23,827.66 | 301.69 | 1.28% |
| NASDAQ | 25,372.01 | 207.65 | 0.83% |
| Nikkei 225 | 62,188.63 | 893.23 | -1.42% |
| NZX 50 Index | 13,783.45 | 63.19 | 0.46% |
| S&P 500 | 7,568.92 | 27.52 | 0.36% |
| S&P/ASX 200 | 8,834.50 | 52.30 | -0.59% |
| SSE Composite Index | 3,673.78 | 65.68 | 1.82% |